Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05472116 · ClinicalTrials.gov registry record
Capillary Refill Time Measurement Utilizing Mobile Application in Children
A clinical trial of Healthy Children (1 Month to 17 Years Old), sponsored by University of Minnesota.
- Completed
- Registry status
- 193
- Enrollment target
- 1
- Study location
NCT05472116: Completed study of Healthy Children (1 Month to 17 Years Old), sponsored by University of Minnesota.
NCT05472116 is a study of Healthy Children (1 Month to 17 Years Old) that has completed, run by University of Minnesota. The registered enrollment target is 193 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05472116, a study of Healthy Children (1 Month to 17 Years Old), has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 193 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the accuracy and precision of capillary refill time measurement using a mobile health application (Cap App) in a healthy pediatric population. This will be a cross-sectional study measuring the capillary refill time in a healthy pediatric population using both the Cap App and two additional manual methods which will serve as the comparison.
Primary Outcome
Capillary refill time (CRT) of Cap App compared to two manual methods
Conditions Studied
Interventions
- DEVICE Mobile Health application (CapApp)
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2022-08-26 |
| Est. Completion | 2023-01-01 |
What the finished NCT05472116 record still lists
NCT05472116 is an observational study that tracks outcomes without assigning an intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Healthy Children (1 Month to 17 Years Old) appearing as the primary indexed condition, and to 1 intervention - of which Mobile Health application (CapApp) is the first listed.
NCT05472116 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05472116 about?
NCT05472116 is a clinical study titled "Capillary Refill Time Measurement Utilizing Mobile Application in Children". To determine the accuracy and precision of capillary refill time measurement using a mobile health application (Cap App) in a healthy pediatric population. This will be a cross-sectional study measuring the capillary refill time in a healthy pediatric population using both the Cap App and two additi...
What is the current status of trial NCT05472116?
This trial is currently completed. The enrollment target is 193 participants. The study started on 2022-08-26. Estimated completion is 2023-01-01.
What conditions does trial NCT05472116 study?
This clinical trial studies the following conditions: Healthy Children (1 Month to 17 Years Old).
What interventions are being tested in trial NCT05472116?
The interventions under investigation include: Mobile Health application (CapApp) (DEVICE).
Who is sponsoring clinical trial NCT05472116?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05472116 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI